Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis

Control of tuberculosis is threatened by widespread emergence of drug resistance in Mycobacterium tuberculosis. Understanding the molecular basis of resistance might lead to development of novel rapid methods for diagnosing drug resistance. We set out to determine the molecular basis of resistance to rifampicin, a major component of multidrug regimens used for treating tuberculosis. Resistance to rifampicin involves alterations of RNA polymerase. The gene that encodes the RNA polymerase subunit beta (rpoB) was cloned. Sequence information from this gene was used to design primers for direct amplification and sequencing of a 411 bp rpoB fragment from 122 isolates of M tuberculosis. Mutations involving 8 conserved aminoacids were identified in 64 of 66 rifampicin-resistant isolates of diverse geographical origin, but in none of 56 sensitive isolates. All mutations were clustered within a region of 23 aminoacids. Thus, substitution of a limited number of highly conserved aminoacids encoded by the rpoB gene appears to be the molecular mechanism responsible for "single step" high-level resistance to rifampicin in M tuberculosis. This information was used to develop a strategy (polymerase chain reaction-single-strand conformation polymorphism) that allowed efficient detection of all known rifampicin-resistant mutants. These findings provide the basis for rapid detection of rifampicin resistance, a marker of multidrug-resistant tuberculosis.

[1]  W. Zillig,et al.  Reconstitution of bacterial DNA‐dependent RNA‐polymerase from isolated subunits as a tool for the elucidation of the role of the subunits in transcription , 1970, FEBS letters.

[2]  S. Cole,et al.  Nucleotide sequence of the first cosmid from the Mycobacterium leprae genome project: structure and function of the Rif‐Str regions , 1993, Molecular microbiology.

[3]  D. Mitchison,et al.  Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis. , 2015, The American review of respiratory disease.

[4]  J. T. Crawford,et al.  IS6110: conservation of sequence in the Mycobacterium tuberculosis complex and its utilization in DNA fingerprinting. , 1991, Molecular and cellular probes.

[5]  D. Mitchison.  Drug resistance in mycobacteria. , 1984, British medical bulletin.

[6]  S. Carbonara,et al.  Emergence of drug-resistant Mycobacterium tuberculosis in HIV-infected patients , 1991, The Lancet.

[7]  M. Tsukamura.  The pattern of resistance development to rifampicin in Mycobacterium tuberculosis. , 1972, Tubercle.

[8]  B. Culliton.  Drug-resistant TB may bring epidemic , 1992, Nature.

[9]  I. Al-Orainey.  Drug resistance in tuberculosis. , 1990, Journal of chemotherapy.

[10]  S. Sommer,et al.  The generation of radiolabeled DNA and RNA probes with polymerase chain reaction. , 1989, Analytical biochemistry.

[11]  M. Fischl,et al.  An Outbreak of Tuberculosis Caused by Multiple-Drug-resistant Tubercle Bacilli among Patients with HIV Infection , 1992, Annals of Internal Medicine.

[12]  S. Siddiqi,et al.  Evaluation of rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis , 1981, Journal of clinical microbiology.

[13]  A. Nagata,et al.  Alteration of ribosomes and RNA polymerase in drug-resistant clinical isolates of Mycobacterium tuberculosis. , 1985, Antimicrobial Agents and Chemotherapy.

[14]  T. Sekiya,et al.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. , 1989, Genomics.

[15]  S. Oldham,et al.  Clinical Presentation and Outcome of Patients with HIV Infection and Tuberculosis Caused by Multiple-Drug-resistant Bacilli , 1992, Annals of Internal Medicine.

[16]  R. Kajioka,et al.  Permeability Barrier to Rifampin in Mycobacteria , 1977, Antimicrobial Agents and Chemotherapy.

[17]  J. T. Crawford,et al.  Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. A risk to patients and health care workers. , 1992, Annals of internal medicine.

[18]  J. McFadden.  Molecular biology of the mycobacteria , 1990 .

[19]  J. T. Crawford,et al.  An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. , 1992, The New England journal of medicine.

[20]  F. Laguna,et al.  AIDS and tuberculosis in Spain. A report of 140 cases. , 1991, The Journal of infection.

[21]  K. Hayashi,et al.  PCR-SSCP: a simple and sensitive method for detection of mutations in the genomic DNA. , 1991, PCR methods and applications.

[22]  S. Cole,et al.  The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis , 1992, Nature.

[23]  Frank,et al.  Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis , 1993, Journal of clinical microbiology.

[24]  C. Gross,et al.  Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance. , 1988, Journal of molecular biology.

[25]  M. Uhlén,et al.  Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support. , 1989, Nucleic acids research.

[26]  V. V. Gubanov,et al.  The primary structure of Escherichia coli RNA polymerase. Nucleotide sequence of the rpoB gene and amino-acid sequence of the beta-subunit. , 1981, European journal of biochemistry.